...
首页> 外文期刊>Frontiers in Pharmacology >Over-expression of a Codon Optimized Yeast Cytosolic Pyruvate Carboxylase (PYC2) in CHO Cells for an Augmented Lactate Metabolism
【24h】

Over-expression of a Codon Optimized Yeast Cytosolic Pyruvate Carboxylase (PYC2) in CHO Cells for an Augmented Lactate Metabolism

机译:CHO细胞中密码子优化的酵母胞溶丙酮酸羧化酶(PYC2)的过度表达,可增强乳酸代谢。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Monoclonal antibodies are the most demanding biotherapeutic drugs now a days used for the cure of various critical illnesses. Chinese hamster ovary (CHO) cells are one of the main hosts used for the large scale production of these antibodies. However, the cell line and production processes are the key factors to determine the cost and affordability of these antibodies. The metabolic waste lactic acid and ammonium are accumulated during a cell culture process and adversely affects productivity as well as product quality. To control the lactate metabolism of mAb (IgG1-kappa) producing CHO clones, we super-transfected the cells with a mammalian construct bearing codon optimized yeast cytosolic pyruvate carboxylase (PYC2) and a strong fusion promoter for optimal expression of PYC2 enzyme. A pool study was also performed for the assessment of cell’s performance, post-translational modification of a mAb and its expression in a CHO clone. The current study resulted an improved mAb titer up to 5%, galactosylation up to 2.5-folds, mannosylation up to twofold and marginal improved main and basic peaks in the charge variant profile at the cell pool stage. Such, approach may be suitable for the implementation in CHO cells producing recombinant protein for a better process control for the production of biotherapeutics.
机译:单克隆抗体是当今用于治疗各种重大疾病的最苛刻的生物治疗药物。中国仓鼠卵巢(CHO)细胞是用于大规模生产这些抗体的主要宿主之一。但是,细胞系和生产工艺是确定这些抗体的成本和负担能力的关键因素。代谢废乳酸和铵在细胞培养过程中积累,对生产率和产品质量产生不利影响。为了控制产生mAb(IgG1-kappa)的CHO克隆的乳酸代谢,我们用带有密码子优化的酵母胞质丙酮酸羧化酶(PYC2)和强力融合启动子的哺乳动物构建体对细胞进行了超转染,以实现PYC2酶的最佳表达。还进行了一项汇总研究,以评估细胞的性能,mAb的翻译后修饰及其在CHO克隆中的表达。当前的研究结果显示,mAb滴度提高了5%,半乳糖基化提高了2.5倍,甘露糖基化提高了2倍,并且在细胞池阶段在电荷变异谱中改善了主要和基本峰。这种方法可能适合在生产重组蛋白的CHO细胞中实施,以更好地控制生产生物疗法的过程。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号